MOLECULAR PARTNERS AG business relationships
Companies named in MOLECULAR PARTNERS AG’s 20-F filed 2026-03-12, and public companies whose annual reports name MOLECULAR PARTNERS AG. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.4 / 10
- AI naming
- 72 / 100 Top 2% in its category
- Agent readiness
- 40 / 100
- AI adoption
- 0 / 100
Named in MOLECULAR PARTNERS AG’s annual report 2
“See "Item 4.B - Business Overview-License and Collaboration Agreements" for information regarding the Novartis Option Agreement, the Ensovibep License Agreement and the Novartis Radioligand Agreement with Novartis.” SEC filing
“Revenues in prior years were exclusively driven by the Novartis collaboration agreement for radioligand therapies.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.